top of page

For Immediate Release

CiNTL Pharma B.V. Signs Industry Collaboration Agreement with Utrecht University of Applied Sciences

Advancing AI-Driven Clinical Research Through Applied Data Science Collaboration


February 20, 2026

Utrecht, The Netherlands, 23 February 2026: CiNTL Pharma B.V., a data-driven Contract Research Organization (CRO), has signed an Industry Collaboration Agreement with Utrecht University of Applied Sciences – Data Driven Business (https://www.hu.nl) to further integrate applied Artificial Intelligence (AI) and Data Science expertise into clinical research operations.

​

Through this collaboration, Master’s students in Data Driven Business, Artificial Intelligence, and Data Science will engage directly within CiNTL’s AI-enabled operations environment. Their work will contribute to advancing intelligent, data-driven business optimization in regulated pharmaceutical and biotech settings.

 

As Europe’s first fully agentic CRO, CiNTL Pharma integrates autonomous AI workflows across clinical operations, risk-based monitoring, clinical data management, and portfolio-level trial intelligence. By embedding academic data science expertise into these workflows, CiNTL continues to accelerate responsible AI adoption within regulated environments.

​

Utrecht University of Applied Sciences maintains a global network of academic and industry partners, supporting practice-oriented innovation. As the University emphasizes, “by adding value to your own organisation, you give our students the opportunity to practice their skills and learn from experienced professionals.” This collaboration reflects a shared commitment to connecting advanced academic training with real-world clinical execution.

​

CiNTL Pharma remains focused on building strategic academic partnerships that strengthen innovation capacity, enhance regulatory readiness, and support the development of next-generation AI talent within the life sciences sector.

​

About CiNTL Pharma B.V.

CiNTL Pharma is a trusted data-driven, female-founded CRO based in the Netherlands. The company is pioneering an agentic AI platform designed to transform clinical research design, regulatory workflows, and trial execution. With a strong focus on automation and equity, CiNTL Pharma empowers pharmaceutical and biotechnology companies to run faster, smarter, and more compliant clinical trials.

​

Website: www.cintlpharma.com

 

For media inquiries, partnerships, or collaborations, please contact CiNTL Pharma Business Development at BD@cintlpharma.com.

​

bottom of page